Latest News about ABBV
Recent news which mentions ABBV
Here's What Warren Buffett Looks For With Healthcare Stocks
October 02, 2021
From Motley Fool
AbbVie Presents New Upadacitinib Data In Atopic Dermatitis
September 30, 2021
Tickers
ABBV
From Benzinga
AbbVie Unveils New Durable Risankizumab Data In Psoriatic Arthritis
September 30, 2021
Tickers
ABBV
From Benzinga
The Daily Biotech Pulse: Merck Confirms Acceleron Purchase, Regeneron Touts COVID-19 Antibody Cocktail Data, Takeda In-Licenses Huntington's Disease Drug
September 30, 2021
From Benzinga
I-Mab In Talks With Pharma Giants About Partnership, Stake Sale: Bloomberg
September 29, 2021
From Benzinga
Here's How a New Investor Started Her Portfolio With Just 10 Top Stocks
September 29, 2021
From Motley Fool
FDA Gives Nod To First Oral CGRP Receptor To Prevent Migraine From AbbVie
September 29, 2021
Tickers
ABBV
From Benzinga
Here's Why Investors Shouldn't Count Out Johnson & Johnson as a Coronavirus Vaccine Stock
September 29, 2021
From Motley Fool
The Daily Biotech Pulse: AbbVie's Migraine Drug OK'd By FDA, Amicus Spins Off Gene Therapy Business, Geovax In-Licenses Cancer Drug
September 29, 2021
From Benzinga
Here's Why AbbVie Is a Great Healthcare Stock for Long-Term Investors
September 29, 2021
From Motley Fool
7 Biotech Stocks Entering the Golden Boom Phase
September 28, 2021
From InvestorPlace
3 Top Stocks for Retirees
September 28, 2021
From Motley Fool
Could AbbVie's New Collaboration Be a Blockbuster?
September 27, 2021
From Motley Fool
3 High-Yield Dividend Stocks Warren Buffett Loves
September 27, 2021
From Motley Fool
3 Top Biotech Stocks to Buy for the Long Haul
September 27, 2021
From Motley Fool
Barron's Latest Picks And Pans: Healthcare Roundtable Picks, Dividend Aristocrats And More
September 25, 2021
From Benzinga
Why AbbVie Just Made a $1.8 Billion Gene Therapy Deal
September 25, 2021
From Motley Fool
Takeda Guilty Of Supply Contract Breach With AbbVie For Prostate Cancer Drug
September 24, 2021
From Benzinga
Put a ‘collar’ on your stocks to protect yourself from a market correction
September 24, 2021
From MarketWatch
3 Relatively Safe Pharma Stocks You Can Buy Right Now
September 23, 2021
From Motley Fool
3 Cheap Healthcare Stocks to Buy Right Now
September 22, 2021
From InvestorPlace
AbbVie Is Worth 28% More Based on Impressive Dividends
September 20, 2021
Tickers
ABBV
From InvestorPlace
Is AbbVie a Bad News Buy?
September 19, 2021
From Motley Fool
AbbVie's Pain Is Sanofi's and Regeneron's Gain
September 18, 2021
From Motley Fool
Why BeiGene's Shares Jumped on Friday
September 17, 2021
From Motley Fool
2 Embarrassingly Cheap Dividend Stocks to Buy
September 16, 2021
From Motley Fool
Is AbbVie's 4.9% Dividend Yield Safe?
September 15, 2021
From Motley Fool
Why Regenxbio Stock Is Way Up Today
September 13, 2021
From Motley Fool
Why Regenxbio Shares Are Trading Higher Today
September 13, 2021
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.